Compared with the difference in efficacy between EGFR-TKIs alone and EGFR-TKIs combined with craniocerebral radiotherapy in EGFR mutant lung adenocarcinoma patients with brain metastasis. A propensity-score matched analysis

被引：0
|
作者：
Deng, G. [1 ]
Li, Z. [1 ]
机构：
[1] Shandong Univ, Shandong Canc Hosp, Jinan, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
10.1016/j.annonc.2022.07.1128
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1002P
引用
收藏
页码：S1012 / S1012
页数：1
相关论文
共 50 条
  • [41] Effects of EGFR-TKIs combined with intracranial radiotherapy in EGFR-mutant non-small cell lung cancer patients with brain metastases: a retrospective multi-institutional analysis
    He, Mingfeng
    Wu, Xue
    Li, Li
    Yi, Guangming
    Wang, Yitian
    He, Hengqiu
    Ye, Ying
    Zhou, Ruiqin
    Xu, Zaicheng
    Yang, Zhenzhou
    RADIATION ONCOLOGY, 2025, 20 (01)
  • [42] Cumulative Smoking Dose Affects the Clinical Outcomes of EGFR-Mutated Lung Adenocarcinoma Patients Treated with EGFR-TKIs
    Kim, I. A.
    Kim, H. J.
    Lee, J. S.
    Lee, K. Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2138 - S2138
  • [43] Stereotactic Radiotherapy Alone for Multiple Brain Metastases after Intracranial Progression in Patients with EGFR-Mutant Lung Adenocarcinoma Receiving EGFR-TKIs: A Multi Center, Single Arm, Phase II Trial
    Ma, Y.
    Yi, J.
    Xing, P.
    Jiang, W.
    Sun, H.
    Zhu, H.
    Li, D.
    Qiao, Q.
    Jiang, X.
    Zhou, R.
    Zhang, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E255 - E255
  • [44] ANALYSIS OF THE EGFR MUTATIONS IN NON-SMALL CELL LUNG CANCER PATIENTS AFTER EGFR-TKIS TREATMENT
    Matsuo, Midori
    Nanae, Tomonaga
    Koichi, Izumikawa
    Hiroyuki, Yamaguchi
    Takaya, Ikeda
    Katsumi, Nakatomi
    Yoichi, Nakamura
    Kazuhiro, Tsukamoto
    Shigeru, Kohno
    RESPIROLOGY, 2010, 15 : 68 - 68
  • [45] Efficacy of first-generation EGFR-TKIs on patients with NSCLC harboring EGFR uncommon mutations: a pooled analysis
    Zhang, Y.
    Tang, S.
    Zhang, J.
    He, Q.
    He, J.
    Liang, W.
    ANNALS OF ONCOLOGY, 2016, 27
  • [46] Outcomes of adjuvant epithelial growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) treatment for EGFR-mutant non-small-cell lung cancer: a propensity-score analysis
    Zhao, Shufen
    Ma, Ge
    Guo, Jing
    Ding, Aiping
    Wang, Shasha
    Yu, Guohong
    Chen, Lei
    Yuan, Yonggang
    Xiao, Wenjing
    SCIENTIFIC REPORTS, 2017, 7
  • [47] Outcomes of adjuvant epithelial growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) treatment for EGFR-mutant non-small-cell lung cancer: a propensity-score analysis
    Shufen Zhao
    Ge Ma
    Jing Guo
    Aiping Ding
    Shasha Wang
    Guohong Yu
    Lei Chen
    Yonggang Yuan
    Wenjing Xiao
    Scientific Reports, 7
  • [48] Factors on survival for patients of EGFR mutation advanced lung adenocarcinoma with EGFR-TKIs combined with radiotherapy: Real-world data from single center.
    Wang, Yuxiang
    Yu, Wenjian
    Shi, Jian
    Jiang, Nan
    Wang, Zhoufan
    Yang, Jie
    Jia, Zhongfei
    Song, Meng
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [49] Comprehensive analysis of aneuploidy status and its effect on the efficacy of EGFR-TKIs in lung cancer
    Wei, Bing
    Zhao, Chengzhi
    Yang, Ke
    Yan, Chi
    Chang, Yuxi
    Gao, Huijie
    Guo, Yongjun
    Ma, Jie
    JOURNAL OF THORACIC DISEASE, 2022, 14 (03) : 625 - +
  • [50] EGFR-TKIs plus local therapy demonstrated survival benefit than TKIs alone in EGFR-mutant NSCLC patients with oligometastatic or oligoprogressive liver metastases
    Jiang, T.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S74 - S74
12345